Table 3. Topics covered in internal horizon scanning reports and purposes.
Topic | Purpose |
---|---|
Beta idursulfase for mucopolysaccharidosis type 2 (Hunter syndrome) | Judicial defense |
Mipomersen for homozygous familial hypercholesterolaemia | |
Eculizumab for paroxysmal nocturnal hemoglobinuria and atypical hemolytic uremic syndrome | |
Metreleptin for Berardinelli-Seip syndrome | |
Pompe disease | Elaboration of PCDT |
Fabry’s disease | |
Mucopolysaccharidoses type 1 and 2 | |
Medicines for familial amyloidotic polyneuropathy associated with transthyretin | |
Watson robot | To inform MH managers |
Rapid diagnostic method of bacterial meningitis | |
Diagnostic method of colorectal cancer by stool DNA | |
Medicines for chronic hepatitis C | |
Severe asthma medications | |
Recombinant factors VIII for Haemophilia A | Research and Development (R&D) |
Medicines for Amyotrophic Lateral Sclerosis | Preparation for patients and MH managers meeting |
PCDT: Brazilian clinical guidelines; MH: Ministry of Health